The Fecal Immunochemical Test (FIT) market is experiencing significant growth, driven by the increasing prevalence of colorectal cancer (CRC), advancements in diagnostic technologies, and a global shift towards preventive healthcare. This non-invasive screening method is gaining prominence due to its accuracy, ease of use, and cost-effectiveness. GET REPORT...